Market Cap 84.90M
Revenue (ttm) 7.00M
Net Income (ttm) -127.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,816.71%
Debt to Equity Ratio 0.00
Volume 227,500
Avg Vol 269,776
Day's Range N/A - N/A
Shares Out 56.60M
Stochastic %K 88%
Beta 1.28
Analysts Sell
Price Target $3.50

Company Profile

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT3789, a selective degrader of SMARCA2 protein for the treatment of advanced or metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion; PRT7732, a selective and orally bioavailable SMARCA2 degraders to treat advanced or metastatic solid tumors; and PRT2527, a cyclin...

Industry: Biotechnology
Sector: Healthcare
Phone: 302 467 1280
Address:
175 Innovation Boulevard, Wilmington, United States
LabPsycho
LabPsycho Oct. 24 at 5:23 PM
$PRLD My calculations suggest this will regroup here around $1.60-$1.64 pause then lunge to $1.89 or above.
0 · Reply
GODOFUSD
GODOFUSD Oct. 23 at 5:46 PM
$BMEA I’m bullish on $BMEA’s future, but without partnerships, shareholders are stuck paying! Good data won’t save us from more dilutions. Look at $CAMP, $PRLD or others with partners absorbing cash burn. Land a deal soon, and we’re moon-bound; otherwise, more dilution will tank us to $0.50!
0 · Reply
exp8triot
exp8triot Oct. 22 at 2:33 PM
$PRLD wanna know what it takes to be a millionaire? Buy at these levels $3/share next month. $5/share by March
0 · Reply
LabPsycho
LabPsycho Oct. 22 at 12:48 PM
$NRIX @outlawinvestor1 If you posted and updated comparison table, $PRLD would move close to the top as 1 month gainers.
1 · Reply
Tradelearner2022
Tradelearner2022 Oct. 22 at 5:00 AM
$PRLD - Not able to understand why it ripped today ?
1 · Reply
StockScanners
StockScanners Oct. 22 at 2:08 AM
$PRLD keep watch if this holds above 1.40
0 · Reply
elitechrisvp
elitechrisvp Oct. 21 at 8:13 PM
$PRLD perky perky 😁👍
0 · Reply
LabPsycho
LabPsycho Oct. 21 at 7:35 PM
$PRLD Right on target - hit the predicted $1.64 today (see below). More ($1.89) to come after a pull back?
1 · Reply
outlawinvestor1
outlawinvestor1 Oct. 21 at 6:40 PM
$PRLD what in the world is happening with prelude today? glad i placed a small bet, but now kicking myself that i didn't invest more.
1 · Reply
exp8triot
exp8triot Oct. 21 at 5:33 PM
$PRLD volume pickin up a bit ..on track for 1 million+ shares traded today..
0 · Reply
Latest News on PRLD
Prelude Announces Presentations at 2025 AACR Annual Meeting

Apr 25, 2025, 4:05 PM EDT - 6 months ago

Prelude Announces Presentations at 2025 AACR Annual Meeting


Prelude Therapeutics Announces $25 Million Private Placement

Dec 11, 2023, 9:34 AM EST - 2 years ago

Prelude Therapeutics Announces $25 Million Private Placement


Prelude Therapeutics Reports Full Year 2021 Financial Results

Mar 16, 2022, 7:30 AM EDT - 3 years ago

Prelude Therapeutics Reports Full Year 2021 Financial Results


Why Did Prelude Therapeutics Stock Tumble To 52-Week Low Today?

Oct 7, 2021, 12:55 PM EDT - 4 years ago

Why Did Prelude Therapeutics Stock Tumble To 52-Week Low Today?


Why BofA Is Turning Bullish On Prelude Therapeutics

Jul 27, 2021, 12:32 PM EDT - 4 years ago

Why BofA Is Turning Bullish On Prelude Therapeutics


LabPsycho
LabPsycho Oct. 24 at 5:23 PM
$PRLD My calculations suggest this will regroup here around $1.60-$1.64 pause then lunge to $1.89 or above.
0 · Reply
GODOFUSD
GODOFUSD Oct. 23 at 5:46 PM
$BMEA I’m bullish on $BMEA’s future, but without partnerships, shareholders are stuck paying! Good data won’t save us from more dilutions. Look at $CAMP, $PRLD or others with partners absorbing cash burn. Land a deal soon, and we’re moon-bound; otherwise, more dilution will tank us to $0.50!
0 · Reply
exp8triot
exp8triot Oct. 22 at 2:33 PM
$PRLD wanna know what it takes to be a millionaire? Buy at these levels $3/share next month. $5/share by March
0 · Reply
LabPsycho
LabPsycho Oct. 22 at 12:48 PM
$NRIX @outlawinvestor1 If you posted and updated comparison table, $PRLD would move close to the top as 1 month gainers.
1 · Reply
Tradelearner2022
Tradelearner2022 Oct. 22 at 5:00 AM
$PRLD - Not able to understand why it ripped today ?
1 · Reply
StockScanners
StockScanners Oct. 22 at 2:08 AM
$PRLD keep watch if this holds above 1.40
0 · Reply
elitechrisvp
elitechrisvp Oct. 21 at 8:13 PM
$PRLD perky perky 😁👍
0 · Reply
LabPsycho
LabPsycho Oct. 21 at 7:35 PM
$PRLD Right on target - hit the predicted $1.64 today (see below). More ($1.89) to come after a pull back?
1 · Reply
outlawinvestor1
outlawinvestor1 Oct. 21 at 6:40 PM
$PRLD what in the world is happening with prelude today? glad i placed a small bet, but now kicking myself that i didn't invest more.
1 · Reply
exp8triot
exp8triot Oct. 21 at 5:33 PM
$PRLD volume pickin up a bit ..on track for 1 million+ shares traded today..
0 · Reply
LabPsycho
LabPsycho Oct. 21 at 4:54 PM
$PRLD If one zooms in on the molecular dynamic simulation I posted below, they can see with atomic resolution residues of the protein that may interact with various moieties of the drug. Here just for kicks, I show the putative (lots of guessing from patent and literature research which of the hundreds of variants of $PRLD 's PRT7732 might be but I think is is at least a reasonable approximation) showing ASN, TYR and LEU in close proximity to the drug. One could refine the drug further to enhance or repel such interactions depending on the goal. Big advantage for me of doing these simulations is spilling pizza grease on the keyboard rather than in the test tubes - Ha
0 · Reply
LabPsycho
LabPsycho Oct. 21 at 4:34 PM
$PRLD @pchr 1. Several potential upcoming milestones 2. Molecular glues / degraders seem to be regaining traction (i.e. $CCCC decent results and several big pharma collaborations and $GLUE recent huge partnership with Novartis with tons of $$$ (120M $ UPFRONT) 3. $PRLD fusing PROTAC / molecular degraders with antibodies (great idea IMO with some likely specialized applications) 4. CEO purchased shares about a year ago 5. Generally drifting up with many other beat down biotechs. 6. Recent phantom spike up to $1.91 (then full retrace) suggests wind of a (positive?) development a few weeks ago 7. My molecular dynamic simulation posted here a couple weeks ago (strong bias! LoL)
0 · Reply
Dizzier47
Dizzier47 Oct. 21 at 4:24 PM
$PRLD still not 5$? miss me
0 · Reply
LabPsycho
LabPsycho Oct. 21 at 4:02 PM
$PRLD inching up towards short-term predicted Target price of 1.64 then on to 1.9 as predicted below
1 · Reply
exp8triot
exp8triot Oct. 21 at 3:11 PM
$PRLD wiggle wiggle
0 · Reply
IsabelSims1079
IsabelSims1079 Oct. 20 at 4:28 PM
$PRLD pioneering science; AITX pioneering automation — Steve Reinharz confirms a profitable quarter and strong year-end outlook.
0 · Reply
LabPsycho
LabPsycho Oct. 15 at 6:01 PM
$PRLD Calculations suggest this has been cleaned out and shined up and ready for the move to $1.64, then + $1.89 IMO.
0 · Reply
Dizzier47
Dizzier47 Oct. 14 at 7:03 PM
$PRLD 1$, 1,20$, 1,50$ or 2$ i do not care give me 15$ already stop teasing
1 · Reply
LabPsycho
LabPsycho Oct. 9 at 2:34 PM
$GLUE Up and over $8 as predicted. I think $PRLD , another molecular glue / degrader company with upcoming clinical results, is next for a strong move.
2 · Reply
LabPsycho
LabPsycho Oct. 6 at 10:19 PM
$PRLD @pchr 1. Several potential upcoming milestones 2. Molecular glues / degraders seem to be regaining traction (i.e. $CCCC decent results and several big pharma collaborations and $GLUE recent huge partnership with Novartis with tons of $$$ (120M $ UPFRONT) 3. $PRLD fusing PROTAC / molecular degraders with antibodies (great idea IMO with some likely specialized applications) 4. CEO purchased shares about a year ago 5. Generally drifting up with many other beat down biotechs. 6. My molecular dynamic simulation posted here a couple weeks ago (strong bias! LoL)
0 · Reply
pchr
pchr Oct. 4 at 6:38 PM
$PRLD could someone elaborate why are you bullish on this stock? Any incoming catalysts?
1 · Reply
elitechrisvp
elitechrisvp Oct. 1 at 2:06 PM
0 · Reply